UFM1 and cancer: In patients with OSCC of T1-3, T2-3, T2-4, T3, T3-4, T4, N1-2, N1-3, N2, N2-3, and M0 stages, elevated UFM1 expression was significantly associated with poor survival time in cancer patients (Figure 4).